GLOBALKRATOM.ORG · Evidence-based policy resources

EMS & Hospital Burden

Published emergency, hospital, anesthesia, and perioperative reports document kratom‑associated clinical events requiring naloxone, airway support, ICU care, dialysis, vasopressors, and management of opioid‑like withdrawal.

⸻ Key Clinical Findings

Acute Overdose & Toxicity
Mitragyna speciosa poisoning: Findings from ten cases

Ten overdoses – 90% depressed consciousness; naloxone prevented intubation in two cases. Opioid‑like toxidrome, response to naloxone, and ICU admission documented.

Read Study →
Accidental Kratom Overdose: Naloxone Response & Rebound Hypoxia

Apnea, cyanosis, pinpoint pupils; naloxone reversed symptoms but rebound hypoxia occurred. Highlights opioid‑like toxidrome and need for 24h observation.

Read Case →
Kratom Ingestion and Emergency Care

Circulatory shock, metabolic acidosis, hypoxia. Required vasopressors, intubation, dialysis. Severe critical illness from kratom alone.

Read Report →
Legally Lethal Kratom: Overdose Potential

Consumed >500g kratom; intubated, AST 1347, ALT 3717, renal injury, 7‑OH >500 ng/mL. 14 days ICU. "Legally lethal."

View Case →
Hospitalization & Critical Care
Multiorgan Dysfunction Related to Kratom Ingestion

Mixed liver injury, renal failure requiring dialysis, colitis, liver transplantation, end‑stage renal disease. Long‑term organ damage.

Read Case →
Rhabdomyolysis, Cardiomyopathy, CVA after Kratom Overdose

CPK 26,989, acute renal failure requiring dialysis, transient cardiomyopathy (EF 31‑35%), multifocal brain infarcts.

Read Case →
Kratom Overdose: Rhabdomyolysis, Hearing Loss, Heart Failure

Acute kidney failure, dialysis, reversible cardiomyopathy (EF <15%), transient hearing loss. ICU‑level toxicity.

Read Report →
Cardiac arrest in healthy young male after kratom ingestion

35‑year‑old cardiac arrest after kratom alone; LVEF 20%, brain infarcts. Catastrophic cardiovascular event.

Read Case →
Perioperative & Anesthesia Risk
Kratom Use: An Emerging Perioperative Nursing Concern

Review of anesthetic resistance, hypertension, emergence delirium, withdrawal. Highlights need for multimodal analgesia and preoperative screening.

Read Review →
Anesthetic Challenges Posed by Heavy Kratom Users

18‑year‑old consuming 35g/day required 6mg/kg propofol, opioid resistance, refractory hypertension, emergence delirium.

Read Case →
Complicated postoperative course secondary to kratom withdrawal

55‑year‑old woman developed withdrawal (hallucinations, fever, tachycardia, hypotension) after surgery, leading to ICU admission for aspiration pneumonia.

Read Case →
Withdrawal in Hospital Settings
Precipitated withdrawal with kratom following naltrexone

Naltrexone triggered severe opioid‑like withdrawal; required ICU and high‑dose benzodiazepines. Physical dependence akin to classic opioids.

Read Case →
Kratom Addiction and Withdrawal managed with clonidine/hydroxyzine

Severe opioid‑like withdrawal (abdominal cramps, sweats, vomiting, diarrhea). Required high‑dose clonidine and inpatient detox.

Read Report →
Kratom dependence contributing to suicide attempt

38‑year‑old escalated to 35‑42 g/day; withdrawal (anxiety, abdominal pain, akathisia); overdosed on psychiatric medications. Kratom directly contributed to suicide attempt.

Read Case →
Complexities of Kratom: Dependence, Withdrawal, Buprenorphine

Chronic user developed withdrawal (COWS 9); required buprenorphine for symptom control. Opioid‑type dependence.

Read Report →

Recurring Clinical Patterns

These patterns, repeatedly documented in peer‑reviewed case reports, indicate that kratom produces clinically significant toxicity requiring acute medical intervention.